Treatment for atrial fibrillation with rapid ventricular response

The first decision is whether the rapid rhythm is making circulation unstable. Very low blood pressure, ongoing chest pain, severe breathing difficulty, altered awareness or signs of shock can require urgent electrical cardioversion in a monitored setting. When circulation is stable, clinicians have time to review symptoms, the likely episode duration, medicines, other heart conditions and possible reversible causes.

An electrocardiogram confirms the rhythm. Additional checks may identify infection, dehydration, an electrolyte disturbance, thyroid disease or another stress on the heart. Correcting that problem can help bring the rate under control.

Rate-control medicines reduce how quickly electrical signals reach the lower chambers. The choice depends on blood pressure, heart pumping function, breathing conditions and current medicines. Rhythm-control treatment may use medicine or an electrical cardioversion for selected patients. Because cardioversion can affect clot-related risk, its timing and any need for anticoagulation must be planned clinically.

After the episode, take medicines exactly as prescribed and keep the arranged follow-up. Record recurrent palpitations, dizziness, breathlessness and the circumstances around them. Avoid doubling a forgotten dose unless your prescriber has specifically instructed this. Ongoing care may include rhythm monitoring, medication adjustment and review of stroke risk.

Seek emergency help for a rapid irregular heartbeat with chest pain, severe shortness of breath, fainting, confusion, collapse or cold clammy skin. New facial weakness, one-sided arm weakness, difficulty speaking, sudden vision loss or abrupt loss of coordination may indicate stroke; call emergency services immediately and note when the symptoms started.

Confirm whether your main strategy is rate control, rhythm control or both, and ask which side effects warrant a call. Discuss what caused or contributed to the episode, how to respond if symptoms recur, whether home pulse measurements would help, and how your personal stroke risk affects anticoagulation decisions.